2nd Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$490,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

Illegal Compounding of Animal Drugs

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
ALANNA PORTER TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); CMS Proposed Rule (Protected Classes, etc.); "Hard to Obtain"; Risk Evaluation and Mitigation Strategies (REMS); Healthcare Exchanges

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Transatlantic Trade & Investment Partnership (TTIP) - Proposed Free Trade Agreement between the European Union and the United States. (Market Access; Industry-Specific Regulation; Broader Rules and Principles and Modes of Co-operation)

LobbyistCovered position, as disclosed
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Average Sales Price; Reimbursement

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Part D; Importation; Non Interference

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
ALANNA PORTER TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Food and Drug Administration Safety & Innovation Act (FDASIA)

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.